Dividend Aristocrats are easily some of the most desirable investments on Wall Street. These are the names that have increased dividends for at least 25 years, providing steadily increasing income to long-term-minded shareholders.
As you can imagine, the companies making up this prestigious list are some of the most recognizable brands in the world. Coca-Cola, Walmart, and Johnson & Johnson are just a few of the household names making the cut.
Here at All Star Charts, we like to stay ahead of the curve. That’s why we’re turning our attention to the future aristocrats. In an effort to seek out the next generation of the cream-of-the-crop dividend plays, we’re curating a list of stocks that have raised their payouts every year for five to nine years.
We call them the Young Aristocrats, and the idea is that these are “stocks that pay you to make money.” Imagine if years of consistent dividend growth and high momentum & relative strength had a baby, leaving you with the best of the emerging dividend giants that are outperforming the averages.
Labor Day weekend in Wisconsin usually means one last summer trip up north for one last summer swim in the lake.
For me, this also meant the final jump off the giant raft we built (a ton of steel sitting on 12 barrels, with multiple jumping platforms and a slide that ends six feet above the water). Then, it was time to bring it back to shore to disassemble it for winter storage.
Driving south toward Milwaukee at the end of the long weekend, I saw all sorts of summer toys being towed home for the winter. While it was not quite as warm as in August and the sunset came a bit sooner than it did in July, it was still a lovely evening and a chance to look back and also look ahead.
Our live Monthly Strategy Session concluded last night. For all the premium subscribers, this is where you can access/rewatch the video.
This post is an exercise we do for the non-members to give them an idea of the research we carry out at All Star Charts.
The Monthly Strategy Calls started out as a selfish endeavour whereby we wanted to stay in the loop and follow the big-picture trends. It's like recentering your navigation system to avoid taking the wrong turn. Then we realised this could be helpful to you guys as well! Just to step back and identify the larger trend.
Watching some of these cryptos, you wouldn't even know Bitcoin just got a 15% haircut after $4B worth of positions were steamrolled.
Take a look at Solana...
We thought that this extension target, particularly in the face of the recent action, would act as a logical level to consolidate these gains. But, buyers have continued their charge.
When the market completely ignores these extensions, that's information...
The Outperformers is our newest scan that pinpoints the very best stocks in the market. It’s the fastest, easiest way to find quality names that are primed for major moves.
The goal is that as the market rally progresses, the sector rotation within the market will reflect in this scan. So while our Top/Down Analysis helps us with the broader view of the market, this Bottom/Up scan makes sure that we catch the slightest change in sentiment.
"I like a $BSX Nov/Mar 50-strike Call Calendar spread for a $1.15 debit or cheaper. This means I’ll be long the March 50 calls and short an equal amount of November 50 calls for a net debit which represents the most I can lose in this trade if it short-circuits on us."
To learn more about the trade and the thinking behind it, click below to watch a replay of the Live Stream.
Key Takeaway: Risks remain elevated from a sentiment perspective. The bulls continue to hold court as bears are relatively absent despite their rise in recent weeks. Though there are signs that the extended reign in optimism may face a new challenge. Earnings revisions have ceased to rise, taking with it a tailwind that has accompanied the bulls for over a year. Without that tailwind, the possibility of a larger sentiment response to downside pressure on stocks increases. Lower prices have a tendency to beget a pessimistic outlook that in turn begets lower prices. This negative feedback loop could fuel a more complete unwind in sentiment than has been seen to date.
From the desk of Steve Strazza @Sstrazza and Ian Culley @Ianculley
We held our September Monthly Strategy Session last night. Premium Members can access and rewatch it here.
Non-members can get a quick recap of the call simply by reading this post each month.
By focusing on long-term, monthly charts, the idea is to take a step back and put things into the context of their structural trends. This is easily one of our most valuable exercises as it forces us to put aside the day-to-day noise and simply examine markets from a “big-picture” point of view.
With that as our backdrop, let’s dive right in and discuss three of the most important charts and/or themes from this month’s call.
JC & Strazza were riffing this morning on the strength in the Medical Equipment space and so we started brainstorming on some names to play since we expect the strength to continue.
There were a few names bandied about, but the chart and setup that most caught my attention was Boston Scientific Corp $BSX.
What I liked most was the recent consolidation which can act as a solid base of support for a move higher -- which would be all-time highs breaking out of a nearly 20 year base! As JC likes to say: "The bigger the base, the higher in space!" Seems this opportunity has a good shot at that:
